On January 28, 2025, the Company received clearance of its IND from the FDA to initiate a first-in-human Phase 1 dose ...

Ring in the new financial year by reviewing your investment plan, estimating your tax outgo, staying on top of deadlines, and ...

Lululemon sales flagged in the Americas during 2024 and mounting headwinds, most especially in the U.S., challenge growth ...

Retirement planning through SIPs is an effective way to build wealth. It’s not just about earnings but wise investing. Start early, stay disciplined, and choose the right mutual funds for a secure ...

A federal judge in Michigan on Wednesday refused to dismiss a lawsuit accusing IBM of forcing out a white male consultant in ...

In August, the Intergovernmental Negotiating Committee (INC) will meet in Geneva for what could be the last chance to force a ...

The FDA has completed its review of the investigational new drug application (IND) for PSV359, and issued a "study may proceed” letter in 1Q 2025. Site activation activities are underway, with the ...

InnoCare Pharma (HKEX: 09969; SSE: 688428), a leading biopharmaceutical company focusing on cancer and autoimmune diseases, today announced the 2024 annual results as of 31 December 2024.

Ultimately, when HR departments lean into technology and shift to a strategic approach, they free themselves up to focus on ...

Security breach: The White House confirmed an extraordinary breach of security involving top government officials — including Vice President JD Vance and Defense Secretary Pete Hegseth — who ...

For premium support please call: For premium support please call: ...

PALO ALTO, Calif., March 27, 2025 /PRNewswire/ -- Kodiak Sciences Inc. (Nasdaq: KOD), today reported recent business highlights and financial results for the fourth quarter and full year ended ...